Ginsenoside Rh2 Mitigates Pediatric Leukemia Through Suppression of Bcl-2 in Leukemia Cells
Background/Aims: Acute myeloid leukemia (AML) is a severe malignant cancer worldwide, in both adult and pediatric patients. Since bone marrow cell transplantation is seriously limited by the availability of the immune-paired donor sources, the therapy for pediatric leukemia remains challenging. Gins...
Main Authors: | Xiaoru Wang, Yulin Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2015-09-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/430383 |
Similar Items
-
Ginsenoside Rh2 Suppresses Neovascularization in Xenograft Psoriasis Model
by: Jing Zhou, et al.
Published: (2015-06-01) -
Anticancer activity of ginsenosides Rh2 on various cancer cells
by: Seun Eui Kim, et al.
Published: (2023-09-01) -
The ways for ginsenoside Rh2 to fight against cancer: the molecular evidences in vitro and in vivo.
by: Qi-rui Hu, et al.
Published: (2023-03-01) -
Probable Mechanisms of Doxorubicin Antitumor Activity Enhancement by Ginsenoside Rh2
by: Alexander Popov, et al.
Published: (2022-01-01) -
How Does Ginsenoside Rh2 Mitigate Adipogenesis in Cultured Cells and Obese Mice?
by: Longyun Zhang, et al.
Published: (2020-05-01)